Revance Therapeutics Inc (NASDAQ:RVNC)

During the Trading Day
16.05 -0.41 / -2.49%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
16.06 +0.0051 / +0.03%
 
Volume: 2.5K
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close16.46
Today’s open16.50
Day’s range15.95 - 16.52
Volume55,550
Average volume (3 months)171,872
Market cap$390.4M
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-362.54%
Earnings growth (next 5 years)--
Revenue growth (last year)-13.95%
P/E ratio5.5
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SCLNSciClone Pharmaceuti...0.000.00%
IMDZImmune Design Corp-1.14-4.92%
SUPNSupernus Pharmaceuti...-0.19-2.07%
ACRXAcelRx Pharmaceutica...-0.10-1.12%
Data as of 4:00pm ET, 02/27/2015

Financials

Next reporting dateMarch 3, 2015
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$617.0K
Annual profit (last year)$258.0K
Net profit margin41.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
L. Daniel Browne
CFO &
Executive VP-Corporate Development
Lauren P. Silvernail
Corporate headquarters
Newark, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account